Clinical Trials Logo
  1. Home
  2. Parkinson Disease(PD)
  3. NCT04748263

Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study) — EYE-ToM  

Alzheimer's Dementia Clinical Trial

Official title:
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)

Clinical Trial Summary

It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior disorders. This kind of disorders are observed in Fronto-Temporal Dementia (FTD), Alzheimer's Dementia (AD) and Parkinson's Disease (PD), with severe deficits in FTD and lighter deficits in AD and PD. One explanation might be that patients apply inappropriate visual exploration strategies to decode emotions and intentions of others. This study aims to test this hypothesis and further to analyse whether different patterns emerge from these pathologies.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04748263
Study type Observational
Source Centre Hospitalier Princesse Grace
Contact
Status Completed
Phase
Start date July 1, 2015
Completion date November 1, 2020
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02959502 - Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression N/A
Completed NCT02759887 - Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD) N/A
Completed NCT01002586 - Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia N/A
Terminated NCT02804789 - European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
Completed NCT02190084 - Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia Phase 4
Completed NCT01409564 - Cilostazol Augmentation Study in Dementia Phase 4
Completed NCT01608217 - Delta-THC in Dementia Phase 2
Completed NCT03928405 - Effect of Virtual Reality on Balance and Gait Speed With Alzheimer's Dementia N/A
Recruiting NCT01195389 - Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease N/A
Completed NCT01585272 - Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia Phase 4
Withdrawn NCT04812769 - Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases N/A